Literature DB >> 1701798

Human natural killer cells express VLA-4 and VLA-5, which mediate their adhesion to fibronectin.

A Gismondi1, S Morrone, M J Humphries, M Piccoli, L Frati, A Santoni.   

Abstract

Very late Ag (VLA)-3, VLA-4, and VLA-5, belonging to the beta-1 subfamily of integrins, have been recently identified as receptors for different binding regions of fibronectin (FN). We have detected VLA-4 and VLA-5, but not VLA-3, on fresh CD3-, CD16+, CD56+ human NK cells by flow cytometry and immunochemical analyses using mAb directed against beta-1, alpha-3, alpha-4, and alpha-5 subunits. Binding assays, performed on FN-coated plates, showed that NK cells specifically adhere to FN and their binding capacity is increased by MgCl2 but not by CaCl2. Using as inhibitory probes a polyclonal antibody against the beta-1 chain of the human FN receptor, the synthetic peptide GRGDSP, which is able to inhibit cellular adhesion mediated by VLA-5, the CS1 fragment, which contains the principal adhesion site in the IIICS domain recognized by VLA-4, and functional mAb directed against alpha-4 or alpha-5 subunits, we show that both VLA-4 and VLA-5 mediate the adhesion of human NK cells to FN. The expression of these integrin receptors may be relevant for NK interaction with extracellular matrix components and other cell types.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1701798

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  25 in total

Review 1.  Anti-integrin immunotherapy in rheumatoid arthritis: protective effect of anti-alpha 4 antibody in adjuvant arthritis.

Authors:  C Barbadillo; A G-Arroyo; C Salas; J Mulero; F Sánchez-Madrid; J L Andreu
Journal:  Springer Semin Immunopathol       Date:  1995

Review 2.  VLA-4 and lymphocyte trafficking in immune-inflammatory states: novel therapeutic approaches in allograft arteriopathy.

Authors:  S Molossi; M Rabinovitch
Journal:  Springer Semin Immunopathol       Date:  1995

Review 3.  Integrins: cell adhesives and modulators of cell function.

Authors:  F T Bosman
Journal:  Histochem J       Date:  1993-07

4.  Antibody to α4 integrin suppresses natural killer cells infiltration in central nervous system in experimental autoimmune encephalomyelitis.

Authors:  Yan Gan; Ruolan Liu; Wei Wu; Roberto Bomprezzi; Fu-Dong Shi
Journal:  J Neuroimmunol       Date:  2012-04-13       Impact factor: 3.478

5.  Vascular cell adhesion molecule-1 and the integrin VLA-4 mediate adhesion of human B cell precursors to cultured bone marrow adherent cells.

Authors:  D H Ryan; B L Nuccie; C N Abboud; J M Winslow
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

6.  Granulated metrial gland cells in the pregnant uterus of mice expressing the collagen mutation tight-skin (Tsk/+).

Authors:  Y Kiso; B A McBey; B A Croy
Journal:  Cell Tissue Res       Date:  1992-05       Impact factor: 5.249

7.  Morphological, phenotypic and functional characteristics of a pure population of CD56+ CD16- CD3- large granular lymphocytes generated from human duodenal mucosa.

Authors:  G Pang; A Buret; R T Batey; Q Y Chen; L Couch; A Cripps; R Clancy
Journal:  Immunology       Date:  1993-07       Impact factor: 7.397

8.  Generation and characterization of two human alpha/beta T cell clones. Recognizing autologous breast tumor cells through an HLA- and TCR/CD3-independent pathway.

Authors:  P Nisticò; P De Berardinis; S Morrone; T Alonzi; C Buono; I Venturo; P G Natali
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

9.  Adhesion to fibronectin primes eosinophils via alpha 4 beta 1 (VLA-4).

Authors:  A R Anwar; G M Walsh; O Cromwell; A B Kay; A J Wardlaw
Journal:  Immunology       Date:  1994-06       Impact factor: 7.397

10.  Generation of cell-derived matrices that support human NK cell migration and differentiation.

Authors:  Barclay J Lee; Everardo Hegewisch Solloa; Michael J Shannon; Emily M Mace
Journal:  J Leukoc Biol       Date:  2020-05-11       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.